Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TAK1–YAP Control of Gastric Cancer Stem Cells
2026-09-20
The reference study identifies TGFβ-activated kinase 1 (TAK1) as an upstream regulator of YAP stability and gastric cancer stem cell self-renewal. Its evidence links IL-6–responsive TAK1 to SOX2 and SOX9 transcription, tumorigenesis, and a mechanistic pathway that may help explain aggressive gastric cancer phenotypes.
-
ECL Western Blotting Substrate: Workflow Guide
2026-09-19
ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection on immunoblots. It is intended for HRP chemiluminescent Western blot assays using X-ray film or CCD imaging, not for fluorescent, radioisotopic, or non-HRP detection workflows.
-
GTP Solution for p21 mRNA-LNP Workflows
2026-09-18
A ready-to-use GTP Solution supports reproducible in vitro transcription, from p21 mRNA production to localized lipid nanoparticle studies. This practical guide connects nucleotide handling, RNA quality control, and the intravesical bladder cancer workflow reported in a 2026 FASEB Journal study.
-
UV-Fenton Degradation of Sulfisomidine
2026-09-18
A 2020 Chemosphere study examined how UV-Fenton treatment degrades sulfisomidine and three other pharmaceuticals in ultrapure water and landfill-derived DTRO concentrate. Its main contribution was to connect degradation kinetics with transformation-product identification and HepG2 cytotoxicity evolution, showing that matrix effects and intermediate toxicity are essential when evaluating treatment performance.
-
Verapamil HCl: Applied Calcium Signaling Workflows
2026-09-17
Use Verapamil HCl as a controlled L-type calcium channel blocker to connect calcium influx, intracellular drug exposure, apoptosis, and inflammatory signaling. This workflow-oriented guide shows how to design myeloma combination studies, arthritis inflammation model experiments, and troubleshooting controls without confusing channel blockade with transporter effects.
-
SD 169: Reading p38 Signals in Dynamic Assays
2026-09-17
SD 169 (indole-5-carboxamide) is a selective ATP-competitive p38α/β inhibitor for dissecting inflammatory, metabolic, and neural signaling. This guide shows how to interpret inhibitor effects alongside p38 dephosphorylation, apoptosis, and functional readouts.
-
Mouse Tissue Lysis Kit K1038: Direct PCR Guide
2026-09-16
The Mouse Tissue Lysis Kit K1038 provides a rapid tissue-digestion step for releasing genomic DNA from mouse tail, toe, or ear samples for direct PCR-based genotyping. It is intended for scientific molecular biology research and DNA analysis, not for diagnostic, clinical, or medical applications.
-
DIDS: Workflow Guide for Chloride and Tumor Stress
2026-09-16
DIDS combines chloride-transport perturbation with a practical way to interrogate cell-death survival, vascular signaling, and tumor-stress phenotypes. This guide connects concentration-aware assay design with the prometastatic-state findings of the reference study while emphasizing solubility, selectivity, and interpretation controls.
-
SU 5402: From RTK Biology to Translational Strategy
2026-09-15
SU 5402 is more than a receptor tyrosine kinase inhibitor: it is a mechanistic probe for testing how VEGFR2, FGFR, PDGFRβ, and downstream ERK1/2–STAT3 signaling shape tumor phenotypes. This thought-leadership perspective connects multiple myeloma research and cancer biology with carefully bounded opportunities in human iPSC-derived sensory neuron models of HSV-1 latency.
-
SU 5402 for Reliable Cell Assays
2026-09-15
A scenario-driven guide to using SU 5402 (SKU A3843) in viability, proliferation, apoptosis, and receptor tyrosine kinase studies. It connects target-level potency, solvent handling, orthogonal readouts, and vendor-selection criteria to improve interpretation and reproducibility.
-
DIDS: Practical Workflows for Chloride and Cancer Studies
2026-09-14
DIDS combines chloride-transport inhibition with context-dependent effects on TRPV1, vascular tone, mitochondrial membrane permeabilization, and tumor-cell stress. This guide translates those properties into assay-ready workflows, controls, troubleshooting decisions, and a cautious strategy for studying prometastatic states after near-death stress.
-
Pertussis toxin: Applied cAMP Research Workflows
2026-09-14
Use Pertussis toxin as a controlled perturbation tool for cAMP signaling, dendritic-cell maturation, and selected Gαi/o-sensitive behavioral assays. This workflow-oriented guide distinguishes literature-backed applications from optimization steps, helping researchers interpret immune, vascular, and neurobehavioral readouts without overgeneralizing across models.
-
HyperScribe™ mRNA Kit: From Cap to Immune Readout
2026-09-13
The HyperScribe All in One mRNA Synthesis Kit Plus 1 enables ARCA-capped, modified, polyadenylated mRNA production for translation and RNA vaccine research. This guide connects its chemistry to assay design, immune-response interpretation, and the spleen-targeted neoantigen vaccine findings reported in Cell Reports Medicine.
-
Tiamulin (Thiamutilin): Applied Research Workflows
2026-09-12
Tiamulin combines targeted antibacterial activity with investigational anti-inflammatory effects, making it useful for pathogen assays, veterinary pharmacology, residue analysis, and pathway-focused cell studies. This workflow-centered guide shows how to prepare, test, troubleshoot, and interpret Tiamulin data across bacterial, animal, and translational models.
-
TAK1–YAP Control of Gastric Cancer Stem Cells
2026-09-11
The reference study identifies TGFβ-activated kinase 1 (TAK1) as an inflammatory, stemness-promoting regulator in gastric cancer. Its key mechanistic contribution is linking IL-6-driven TAK1 expression to stabilization of YAP, increased SOX2 and SOX9 transcription, gastric cancer stem-cell self-renewal, and tumorigenesis.